{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T22:26:59Z","timestamp":1791584819568,"version":"4.3.4"},"reference-count":95,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2022,5,29]],"date-time":"2022-05-29T00:00:00Z","timestamp":1653782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014434","name":"Polish National Academic Exchange Program (NAWA)","doi-asserted-by":"publisher","award":["PPN\/ULM\/2019\/1\/00297\/U\/00001"],"award-info":[{"award-number":["PPN\/ULM\/2019\/1\/00297\/U\/00001"]}],"id":[{"id":"10.13039\/501100014434","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Alzheimer\u2019s disease (AD) is multifactorial, progressive and the most predominant cause of cognitive impairment and dementia worldwide. The current \u201cone-drug, one-target\u201d approach provides only symptomatic relief to the condition but is unable to cure the disease completely. The conventional single-target therapeutic approach might not always induce the desired effect due to the multifactorial nature of AD. Hence, multitarget strategies have been proposed to simultaneously knock out multiple targets involved in the development of AD. Herein, we provide an overview of the various strategies, followed by the multitarget-directed ligand (MTDL) development, rationale designs and efficient examples. Furthermore, the effects of the linkers and substitutional functional groups on MTDLs against various targets of AD and their modes of action are also discussed.<\/jats:p>","DOI":"10.3390\/ijms23116085","type":"journal-article","created":{"date-parts":[[2022,5,29]],"date-time":"2022-05-29T08:50:51Z","timestamp":1653814251000},"page":"6085","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Effects of Linkers and Substitutions on Multitarget Directed Ligands for Alzheimer\u2019s Diseases: Emerging Paradigms and Strategies"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6278-1218","authenticated-orcid":false,"given":"Narayanaperumal","family":"Pravin","sequence":"first","affiliation":[{"name":"Department of Biopharmacy, Medical University of Lublin, Chodzki 4a, 20-093 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6018-5092","authenticated-orcid":false,"given":"Krzysztof","family":"Jozwiak","sequence":"additional","affiliation":[{"name":"Department of Biopharmacy, Medical University of Lublin, Chodzki 4a, 20-093 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,5,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.drudis.2013.01.008","article-title":"Shifting from the single to the multitarget paradigm in drug discovery","volume":"18","author":"Giulianotti","year":"2013","journal-title":"Drug Discov. Today"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nchembio.118","article-title":"Network pharmacology: The next paradigm in drug discovery","volume":"4","author":"Hopkins","year":"2008","journal-title":"Nat. Chem. Biol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1586\/ecp.11.13","article-title":"The use of multi-target drugs in the treatment of neurodegenerative diseases","volume":"4","year":"2011","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ejmech.2017.05.016","article-title":"Designing multi-targeted agents: An emerging anticancer drug discovery paradigm","volume":"136","author":"Fu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, Inflammation, and Cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"ref_6","first-page":"459","article-title":"Alzheimer\u2019s disease facts and figures","volume":"12","author":"Gaugler","year":"2016","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_7","unstructured":"(2022, April 05). Dementia\u2014World Health Organization 2021. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dementia."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/jnnp.66.2.137","article-title":"The cholinergic hypothesis of Alzheimer\u2019s disease: A review of progress","volume":"66","author":"Francis","year":"1999","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer\u2019s disease: The amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0891-5849(96)00629-6","article-title":"Oxidative Stress Hypothesis in Alzheimer\u2019s Disease","volume":"23","author":"Markesbery","year":"1997","journal-title":"Free. Radic. Biol. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.2174\/0929867311320130004","article-title":"Polypharmacology in a Single Drug: Multitarget Drugs","volume":"20","author":"Bolognesi","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"128574","DOI":"10.1016\/j.bmcl.2022.128574","article-title":"Development of naringenin-O-carbamate derivatives as multi-target-directed liagnds for the treatment of Alzheimer\u2019s disease","volume":"60","author":"Mi","year":"2022","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"116742","DOI":"10.1016\/j.bmc.2022.116742","article-title":"Advancements in the development of multi-target directed ligands for the treatment of Alzheimer\u2019s disease","volume":"61","author":"Kumar","year":"2022","journal-title":"Bioorganic Med. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"113441","DOI":"10.1016\/j.ejmech.2021.113441","article-title":"Synthesis and evaluation of multi-target-directed ligands with BACE-1 inhibitory and Nrf2 agonist activities as potential agents against Alzheimer\u2019s disease","volume":"219","author":"Qu","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2174\/138945012799499794","article-title":"Ladostigil: A novel multimodal neuroprotective drug with cholinesterase and brain-selective monoamine oxidase inhibitory activities for Alzheimer\u2019s disease treatment","volume":"13","author":"Weinreb","year":"2012","journal-title":"Curr. Drug Targets"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1002\/med.21699","article-title":"From combinations to multitarget-directed ligands: A continuum in Alzheimer\u2019s disease polypharmacology","volume":"41","author":"Albertini","year":"2021","journal-title":"Med. Res. Rev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"114045","DOI":"10.1016\/j.ejmech.2021.114045","article-title":"The novel therapeutic strategy of vilazodone-donepezil chimeras as potent triple-target ligands for the potential treatment of Alzheimer\u2019s disease with comorbid depression","volume":"229","author":"Li","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"104974","DOI":"10.1016\/j.bioorg.2021.104974","article-title":"Amiridine-piperazine hybrids as cholinesterase inhibitors and potential multitarget agents for Alzheimer\u2019s disease treatment","volume":"112","author":"Makhaeva","year":"2021","journal-title":"Bioorganic Chem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.neulet.2005.01.031","article-title":"Cognitive correlates of alterations in acetylcholinesterase in Alzheimer\u2019s disease","volume":"380","author":"Bohnen","year":"2005","journal-title":"Neurosci. Lett."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1756-6606-4-3","article-title":"APP processing in Alzheimer\u2019s disease","volume":"4","author":"Zhang","year":"2011","journal-title":"Mol. Brain"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/sj.mp.4001967","article-title":"Validation of amyloid-\u03b2 peptides in CSF diagnosis of neurodegenerative dementias","volume":"12","author":"Bibl","year":"2007","journal-title":"Mol. Psychiatry"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1093\/brain\/awl063","article-title":"CSF amyloid-\u03b2-peptides in Alzheimer\u2019s disease, dementia with Lewy bodies and Parkinson\u2019s disease dementia","volume":"129","author":"Bibl","year":"2006","journal-title":"Brain"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"146","DOI":"10.4103\/0973-1229.58825","article-title":"Stahl\u2019s Essential Psychopharmacology: Neuroscientific Basis and Practical Applications","volume":"8","author":"Andrade","year":"2010","journal-title":"Mens Sana Monogr."},{"key":"ref_24","unstructured":"(2022, April 05). Drug Approval Package: Aduhelm (Aducanumab-Avwa), Available online: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2021\/761178Orig1s000TOC.cfm."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.bbadis.2013.10.015","article-title":"Oxidative stress and mitochondrial dysfunction in Alzheimer\u2019s disease","volume":"1842","author":"Wang","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"325","DOI":"10.5607\/en.2015.24.4.325","article-title":"The Role of Oxidative Stress in Neurodegenerative Diseases","volume":"24","author":"Kim","year":"2015","journal-title":"Exp. Neurobiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.redox.2017.08.010","article-title":"A reciprocal relationship between reactive oxygen species and mitochondrial dynamics in neurodegeneration","volume":"14","author":"Hung","year":"2018","journal-title":"Redox Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2217\/bmm-2017-0456","article-title":"Oxidative stress as a biomarker for Alzheimer\u2019s disease","volume":"12","author":"Collin","year":"2018","journal-title":"Biomark. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.biopha.2015.12.024","article-title":"The influence of common free radicals and antioxidants on development of Alzheimer\u2019s Disease","volume":"78","author":"Oniszczuk","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1196\/annals.1306.012","article-title":"Redox-Active Metals, Oxidative Stress, and Alzheimer\u2019s Disease Pathology","volume":"1012","author":"Huang","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ejmech.2018.09.031","article-title":"Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer\u2019s disease","volume":"158","author":"Li","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nrg2918","article-title":"Network medicine: A network-based approach to human disease","volume":"12","author":"Gulbahce","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drudis.2006.11.008","article-title":"Multi-target therapeutics: When the whole is greater than the sum of the parts","volume":"12","author":"Zimmermann","year":"2007","journal-title":"Drug Discov. Today"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejmech.2014.01.060","article-title":"Multifunctional compounds: Smart molecules for multifactorial diseases","volume":"76","author":"Bansal","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1159\/000347140","article-title":"Adherence to cholinesterase inhibitors in Alzheimer\u2019s Disease: A review","volume":"35","author":"Brady","year":"2013","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/cbic.201402718","article-title":"Tools of the Trade: Investigations into Design Strategies of Small Molecules to Target Components in Alzheimer\u2019s Disease","volume":"16","author":"Derrick","year":"2015","journal-title":"ChemBioChem"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1021\/jm7009364","article-title":"Multi-target-Directed Ligands To Combat Neurodegenerative Diseases","volume":"51","author":"Cavalli","year":"2008","journal-title":"J. Med. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.2174\/15680266113139990135","article-title":"The Multifactorial Nature of Alzheimer\u2019s Disease for Developing Potential Therapeutics","volume":"13","author":"Carreiras","year":"2014","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1002\/anie.200603866","article-title":"Lockman, Combating Alzheimer\u2019s Disease with Multifunctional Molecules Designed for Metal Passivation","volume":"46","author":"Schugar","year":"2007","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1021\/acschemneuro.7b00454","article-title":"Tuning Structures and Properties for Developing Novel Chemical Tools toward Distinct Pathogenic Elements in Alzheimer\u2019s Disease","volume":"9","author":"Han","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.1021\/jm058225d","article-title":"Designed Multiple Ligands. An Emerging Drug Discovery Paradigm","volume":"48","author":"Morphy","year":"2005","journal-title":"J. Med. Chem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1021\/ar500152x","article-title":"The ongoing search for small molecules to study metal-Associated amyloid-\u03b2 species in alzheimers disease","volume":"47","author":"Savelieff","year":"2014","journal-title":"Acc. Chem. Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1021\/acs.chemrev.8b00138","article-title":"Development of multifunctional molecules as potential therapeutic candidates for Alzheimer\u2019s disease, Parkinson\u2019s disease, and amyotrophic lateral sclerosis in the last decade","volume":"119","author":"Savelieff","year":"2019","journal-title":"Chem. Rev."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"17S","DOI":"10.1177\/0091270006288735","article-title":"Rationale for Combination Therapy with Galantamine and Memantine in Alzheimer\u2019s Disease","volume":"46","author":"Grossberg","year":"2006","journal-title":"J. Clin. Pharmacol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"9708","DOI":"10.1021\/jm3009458","article-title":"Combining galantamine and memantine in multitargeted, new chemical entities potentially useful in Alzheimer\u2019s disease","volume":"55","author":"Simoni","year":"2012","journal-title":"J. Med. Chem."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"8985","DOI":"10.1021\/acs.jmedchem.5b01325","article-title":"Tacrine-Trolox Hybrids: A Novel Class of Centrally Active, Nonhepatotoxic Multi-Target-Directed Ligands Exerting Anticholinesterase and Antioxidant Activities with Low in Vivo Toxicity","volume":"58","author":"Nepovimova","year":"2015","journal-title":"J. Med. Chem."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"8616","DOI":"10.1021\/acs.jmedchem.5b01222","article-title":"Design, synthesis, and evaluation of orally available clioquinol-moracin M hybrids as multitarget-directed ligands for cognitive improvement in a rat model of neurodegeneration in Alzheimer\u2019s disease","volume":"58","author":"Wang","year":"2015","journal-title":"J. Med. Chem."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1002\/cmdc.201600014","article-title":"Novel 8-Hydroxyquinoline Derivatives as Multitarget Compounds for the Treatment of Alzheimer\u2032s Disease","volume":"11","author":"Prati","year":"2016","journal-title":"ChemMedChem"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"7139","DOI":"10.1039\/C5RA26797H","article-title":"Design, synthesis and evaluation of clioquinol-ebselen hybrids as multi-target-directed ligands against Alzheimer\u2019s disease","volume":"6","author":"Wang","year":"2016","journal-title":"RSC Adv."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.ejmech.2018.06.044","article-title":"Tacripyrimidines, the first tacrine-dihydropyrimidine hybrids, as multi-target-directed ligands for Alzheimer\u2019s disease","volume":"155","author":"Chioua","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1021\/acschemneuro.5b00224","article-title":"Novel 1-Phenyl-3-hydroxy-4-pyridinone Derivatives as Multifunctional Agents for the Therapy of Alzheimer\u2019s Disease","volume":"7","author":"Sheng","year":"2016","journal-title":"ACS Chem. Neurosci."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1021\/acsmedchemlett.7b00463","article-title":"Dual GSK-3\u03b2\/AChE Inhibitors as a New Strategy for Multitargeting Anti-Alzheimer\u2019s Disease Drug Discovery","volume":"9","author":"Jiang","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"103721","DOI":"10.1016\/j.bioorg.2020.103721","article-title":"Tacrine-hydroxamate derivatives as multitarget-directed ligands for the treatment of Alzheimer\u2019s disease: Design, synthesis, and biological evaluation","volume":"98","author":"Xu","year":"2020","journal-title":"Bioorganic Chem."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1900041","DOI":"10.1002\/ardp.201900041","article-title":"Anti-Alzheimer\u2019s multitarget-directed ligands with serotonin 5-HT6 antagonist, butyrylcholinesterase inhibitory, and antioxidant activity","volume":"352","author":"Marcinkowska","year":"2019","journal-title":"Arch. Pharm."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1747-0285.2011.01216.x","article-title":"Synthesis and Comparison of Antioxidant Properties of Indole-Based Melatonin Analogue Indole Amino Acid Derivatives","volume":"79","author":"Suzen","year":"2012","journal-title":"Chem. Biol. Drug Des."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.3762\/bjoc.14.104","article-title":"Synthesis of pyrazolopyrimidinones using a \u201cone-pot\u201d approach under microwave irradiation","volume":"14","author":"Kelada","year":"2018","journal-title":"Beilstein J. Org. Chem."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"127254","DOI":"10.1016\/j.bmcl.2020.127254","article-title":"Design, synthesis and evaluation of pyrazolopyrimidinone derivatives as novel PDE9A inhibitors for treatment of Alzheimer\u2019s disease","volume":"30","author":"Zhang","year":"2020","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1021\/acschemneuro.7b00268","article-title":"Discovery of Novel Pyrazolopyrimidinone Derivatives as Phosphodiesterase 9A Inhibitors Capable of Inhibiting Butyrylcholinesterase for Treatment of Alzheimer\u2019s Disease","volume":"8","author":"Yu","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1021\/acschemneuro.8b00376","article-title":"Design, Synthesis, and Biological Evaluation of Dual-Target Inhibitors of Acetylcholinesterase (AChE) and Phosphodiesterase 9A (PDE9A) for the Treatment of Alzheimer\u2019s Disease","volume":"10","author":"Hu","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ejmech.2018.08.005","article-title":"Donepezil-butylated hydroxytoluene (BHT) hybrids as Anti-Alzheimer\u2019s disease agents with cholinergic, antioxidant, and neuroprotective properties","volume":"157","author":"Cai","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"5625","DOI":"10.2174\/0929867325666180517094023","article-title":"A Systematic Review on Donepezil-based Derivatives as Potential Cholinesterase Inhibitors for Alzheimer\u2019s Disease","volume":"26","author":"Korabecny","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Queda, F., Cal\u00f2, S., Gwizdala, K., Magalh\u00e3es, J.D., Cardoso, S.M., Chaves, S., Piemontese, L., and Santos, M.A. (2021). Novel Donepezil\u2013Arylsulfonamide Hybrids as Multitarget-Directed Ligands for Potential Treatment of Alzheimer\u2019s Disease. Molecules, 26.","DOI":"10.3390\/molecules26061658"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"772","DOI":"10.2174\/1567205016666190228122956","article-title":"Donepezil Derivatives Targeting Amyloid-\u03b2 Cascade in Alzheimer\u2019s Disease","volume":"16","author":"Mezeiova","year":"2019","journal-title":"Curr. Alzheimer Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"9089","DOI":"10.1021\/jm401047q","article-title":"Synthesis and evaluation of multi-target-directed ligands against Alzheimer\u2019s disease based on the fusion of donepezil and ebselen","volume":"56","author":"Luo","year":"2013","journal-title":"J. Med. Chem."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1080\/14756366.2018.1491564","article-title":"Donepezil structure-based hybrids as potential multifunctional anti-Alzheimer\u2019s drug candidates","volume":"33","author":"Piemontese","year":"2018","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1021\/acschemneuro.8b00699","article-title":"Novel Deoxyvasicinone-Donepezil Hybrids as Potential Multitarget Drug Candidates for Alzheimer\u2019s Disease","volume":"10","author":"Du","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ejmech.2017.02.043","article-title":"Design, synthesis and evaluation of novel feruloyl-donepezil hybrids as potential multitarget drugs for the treatment of Alzheimer\u2019s disease","volume":"130","author":"Dias","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.1016\/j.bmc.2016.07.025","article-title":"Synthesis and evaluation of multi-target-directed ligands for the treatment of Alzheimer\u2019s disease based on the fusion of donepezil and melatonin","volume":"24","author":"Wang","year":"2016","journal-title":"Bioorganic Med. Chem."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1021\/acschemneuro.7b00257","article-title":"Rational Design and Multibiological Profiling of Novel Donepezil-Trolox Hybrids against Alzheimer\u2019s Disease, with Cholinergic, Antioxidant, Neuroprotective, and Cognition Enhancing Properties","volume":"8","author":"Cai","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Eckroat, T.J., Manross, D.L., and Cowan, S.C. (2020). Merged Tacrine-Based, Multitarget-Directed Acetylcholinesterase Inhibitors 2015\u2013Present: Synthesis and Biological Activity. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21175965"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"33851","DOI":"10.1039\/C7RA04385F","article-title":"Design, synthesis, in vitro and in vivo evaluation of tacrine-cinnamic acid hybrids as multi-target acetyl- and butyrylcholinesterase inhibitors against Alzheimer\u2019s disease","volume":"7","author":"Chen","year":"2017","journal-title":"RSC Adv."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"4972","DOI":"10.1021\/acs.jmedchem.1c00048","article-title":"Bolognesi, Sustainable Drug Discovery of Multi-Target-Directed Ligands for Alzheimer\u2019s Disease","volume":"64","author":"Rossi","year":"2021","journal-title":"J. Med. Chem."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1021\/acschemneuro.1c00507","article-title":"Structural Modification, in Vitro, in Vivo, Ex Vivo, and in Silico Exploration of Pyrimidine and Pyrrolidine Cores for Targeting Enzymes Associated with Neuroinflammation and Cholinergic Deficit in Alzheimer\u2019s Disease","volume":"12","author":"Javed","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ejmech.2016.10.060","article-title":"A review on tacrine-based scaffolds as multi-target drugs (MTDLs) for Alzheimer\u2019s disease","volume":"128","author":"Sameem","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1021\/acs.jmedchem.5b01119","article-title":"Novel Tacrine-Benzofuran Hybrids as Potent Multitarget-Directed Ligands for the Treatment of Alzheimers Disease: Design, Synthesis, Biological Evaluation, and X-ray Crystallography","volume":"59","author":"Zha","year":"2016","journal-title":"J. Med. Chem."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ejmech.2018.02.023","article-title":"Novel Tacrine-Hydroxyphenylbenzimidazole hybrids as potential multitarget drug candidates for Alzheimer\u2019s disease","volume":"148","author":"Hiremathad","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ejmech.2016.03.077","article-title":"Design, synthesis and evaluation of novel tacrine-multialkoxybenzene hybrids as multi-targeted compounds against Alzheimer\u2019s disease","volume":"116","author":"Zhang","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"111958","DOI":"10.1016\/j.ejmech.2019.111958","article-title":"Apigenin-rivastigmine hybrids as multi-target-directed liagnds for the treatment of Alzheimer\u2019s disease","volume":"187","author":"Sang","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.bmc.2015.01.005","article-title":"Multifunctional scutellarin\u2013rivastigmine hybrids with cholinergic, antioxidant, biometal chelating and neuroprotective properties for the treatment of Alzheimer\u2019s disease","volume":"23","author":"Sang","year":"2015","journal-title":"Bioorganic Med. Chem."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cbi.2016.05.001","article-title":"Coumarins as cholinesterase inhibitors: A review","volume":"254","year":"2016","journal-title":"Chem. Biol. Interact."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ejmech.2014.10.029","article-title":"In silico design of novel 2H-chromen-2-one derivatives as potent and selective MAO-B inhibitors","volume":"89","author":"Pisani","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.bioorg.2018.09.010","article-title":"Coumarin-dithiocarbamate hybrids as novel multitarget AChE and MAO-B inhibitors against Alzheimer\u2019s disease: Design, synthesis and biological evaluation","volume":"81","author":"He","year":"2018","journal-title":"Bioorganic Chem."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1002\/cmdc.201500392","article-title":"Multitarget Strategy to Address Alzheimer\u2019s Disease: Design, Synthesis, Biological Evaluation, and Computational Studies of Coumarin-Based Derivatives","volume":"11","author":"Montanari","year":"2016","journal-title":"ChemMedChem"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ejmech.2015.03.040","article-title":"Multi-target tacrine-coumarin hybrids: Cholinesterase and monoamine oxidase B inhibition properties against Alzheimer\u2019s disease","volume":"95","author":"Xie","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"4825","DOI":"10.1080\/07391102.2018.1564701","article-title":"Computational approach to suggest a new multi-target-directed ligand as a potential medication for Alzheimer\u2019s disease","volume":"37","author":"Eslami","year":"2019","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1007\/s00044-014-0931-2","article-title":"Design and synthesis of tacrine-phenothiazine hybrids as multitarget drugs for Alzheimer\u2019s disease","volume":"23","author":"Hui","year":"2014","journal-title":"Med. Chem. Res."},{"key":"ref_87","first-page":"1030","article-title":"3-Aryl-1-Phenyl-1H-Pyrazole Derivatives as New Multitarget Directed Ligands for the Treatment of Alzheimer\u2019s Disease, with Acetylcholinesterase and Monoamine Oxidase Inhibitory Properties","volume":"12","author":"Kumar","year":"2013","journal-title":"EXCLI J."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"28182","DOI":"10.1021\/acsomega.1c04252","article-title":"Halogenated Coumarin\u2212Chalcones as Multifunctional Monoamine Oxidase-B and Butyrylcholinesterase Inhibitors","volume":"6","author":"Rehuman","year":"2021","journal-title":"ACS Omega"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1158\/0008-5472.CAN-05-1182","article-title":"Activity of the Dual Kinase Inhibitor Lapatinib (GW572016) against HER-2-Overexpressing and Trastuzumab-Treated Breast Cancer Cells","volume":"66","author":"Konecny","year":"2006","journal-title":"Cancer Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"907","DOI":"10.2174\/1568026616666160927155515","article-title":"Hybrid Compounds as Multitarget Directed Anticancer Agents","volume":"17","author":"Kucuksayan","year":"2016","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"536","DOI":"10.4158\/EP13176.CS","article-title":"American Association of Clinical Endocrinologists\u2019 comprehensive diabetes management algorithm 2013 consensus statement\u2014Executive summary","volume":"19","author":"Garber","year":"2013","journal-title":"Endocr. Pract."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12933-019-0828-y","article-title":"Sotagliflozin, the first dual SGLT inhibitor: Current outlook and perspectives","volume":"18","author":"Cefalo","year":"2019","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"536","DOI":"10.5694\/j.1326-5377.2004.tb06441.x","article-title":"Effectiveness and side effects of thiazolidinediones for type 2 diabetes: Real-life experience from a tertiary hospital","volume":"181","author":"Hussein","year":"2004","journal-title":"Med. J. Aust."},{"key":"ref_94","unstructured":"(2022, April 06). Trial of ARV-110 in Patients with Metastatic Castration Resistant Prostate Cancer\u2014Full Text View\u2014ClinicalTrials.gov, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03888612."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"5154","DOI":"10.1126\/sciadv.aay5154","article-title":"Light-induced control of protein destruction by opto-PROTAC","volume":"6","author":"Liu","year":"2020","journal-title":"Sci. Adv."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/11\/6085\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:20:48Z","timestamp":1760138448000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/11\/6085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,29]]},"references-count":95,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,6]]}},"alternative-id":["ijms23116085"],"URL":"https:\/\/doi.org\/10.3390\/ijms23116085","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,29]]}}}